Abstract
The ability to grow breast cancer cells in vitro has lead to the identification of several polypeptide hormones that may regulate their growth. The insulin- like growth factors (IGFs) have been identified as potent mitogens for breast cancer cells in vitro and increasing evidence has suggested that the IGFs may have an important function in the proliferation of mammary epithelia. This chapter will examine the data that support a role for the IGFs in regulating the growth of breast cancer cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Daughaday WH, Rotwein P, 1989. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 10:68–91.
Scott J, Cowell J, Robertson ME, Priestley LM, Wadey R, Hopkins B, Pritchard J, Bell GI, Rall LB, Graham CF, Knott TJ, 1985. Insulin-like growth factor-II gene expression in Wilms’ tumour and embryonic tissues. Nature 317:260–262.
Jansen M, VanSchaik FMA, Richer AT, Bullock B, Woods DE, Gabbay KH, Nussbaum AL, Sussenbach JS, Van den Brande JL, 1983. Sequence of cDNA encoding human insulin-like growth factor I precursor. Nature 306:604–611.
Hudson P, John M, Crawford R, Haralambidis J, Scanlon D, Gorman J, Tregear G, Shine J, Niall H, 1984. Relaxin gene expression in human ovaries and the predicted structure of a human preprorelaxin by analysis of cDNA clones. EMBO J 3:2333–2339.
Han VKM, Lund PK, Lee DC, D’Ercole AJ, 1988. Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: Identification, characterization, and tissue distribution. J Clin Endocrinol Metab 66:422–429.
D’Ercole AJ, Hill DJ, Strain AJ, Underwood LE, 1986. Tissue and plasma somatomedin-C/insulin-like growth factor-I concentrations in the human fetus during the 1st half of gestation. Pediatr Res 20:253–255.
Romanus JA, Yang YW-H, Adams SO, Sofair AN, Tseng LT-H, Nissley SP, Rechler MM, 1988. Synthesis of insulin-like growth factor II (IGF-II) in fetal rat tissues: Translation of IGF-II ribonucleic acid and processing of pre-pro-IGF-II. Endocrinology 122: 709–716.
Frunzio R, Chiariotti L, Brown AL, Graham DE, Rechler MM, Bruni CB, 1986. Structure and expression of the rat insulin-like growth factor II (rIGF-II) gene, rIGF-II RNAs are transcribed from two promoters. J Biol Chem 261:17138–17149.
Blum WF, Ranke MB, Bierich JR, 1986. Isolation and partial characterization of 6 somatomedin-like peptides from human plasma Cohn fraction IV. Acta Endocrinol 111: 271–284.
Gowan LK, Hampton B, Hill DJ, Schlueter RJ, Perdue JF, 1987. Purification and characterization of a unique high molecular weight form of insulin-like growth factor II. Endocrinology 121:449–458.
Ullrich A, Gray A, Tarn AW, YangFeng T, Tsubokawa, M, Collins C, Henzel W, LeBon T, Kathuria, S, Chen E, Jacobs S; Francke U, Ramachandran J, Fujita-Yamaguchi Y, 1986. Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggests structural determinants that define hormonal specificity. Embo J 5:2503–2512.
McDonald RG, Pfeffer SR, Coussens L, Tepper MA, Brocklebank CM, Mole JE, Anderson JK, Chen E, Czech MP, Ullrich A, 1988. A single receptor binds both insulin-like growth factor II and mannose-6-phosphate. Science 239:1134–1137.
Morgan DO, Edman JC, Standring DN, Fried VA, Smith MC, Roth RA, Rutter WJ, 1987. Insulin-like growth factor II receptor as a multifunctional binding protein. Nature 329:301–307.
Roth RA, 1988. Structure of the receptor for insulin-like growth factor II: The puzzle amplified. Science 239:1269–1271.
Baxter RC, Martin JL, 1989. Binding proteins for the insulin-like growth factors: Structure, regulation and function. Prog Growth Factor Res 1:49–68.
Wood WI, Cachianes G, Henzel WJ, Winslow GA, Spencer SA, Hellmiss R, Martin JL, Baxter RC, 1988. Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. Mol Endocrinol 2:1176–1185.
Lee YL, Hintz RL, James PM, Lee PDK, Shively JE, Powell DR, 1988. Insulin-like growth factor (IGF) binding protein cDNA from human HEP G2 hepatoma cells: Predicted protein sequence suggests an IGF binding domain different from those of the IGF-I and IGF-II receptors. Mol Endocrinol 2:404–411.
Brewer M, Stetler GL, Squires CH, Thompson RC, Busby WH, Clemmons DR, 1988. Cloning, characterization, and expression of a human insulin-like growth factor binding protein. Biochem Biophys Res Comm 152:1289–1297.
Busby WH Jr, Klapper DG, Clemmons DR, 1988. Purification of a 31,000-dalton insulin-like growth factor binding protein from human amniotic fluid, isolation of two forms with different biological actions. J Biol Chem 263:14203–14210.
De Mellow JSM, Baxter RC 1988. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Comm 156:199–204.
Yee D, Cullen KJ, Paik S, Perdue JF, Hampton B, Schwartz A, Lippman ME, Rosen N, 1988. Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res 48:6691–6696.
Myal Y, Shiu RPC, Bhaumick B, Bala M, 1984. Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture. Cancer Res 44:5486–5490.
Furlanetto RW, DiCarlo JN, 1984. Somatomedin-C receptors and growth effects in human breast cells maintained in long term tissue culture. Cancer Res 44:2122–2128.
Zugmaier G, Knabbe C, Beschauer B, Ennis BW, Lippman ME, Dickson RB, 1989. Estradiol is synergistic with IGF1 or EGF to stimulate anchorage independent growth of estrogen receptor positive human breast cancer cells in serum supplemented but not in serum free agar. J Cell Biochem S13B, Abs E450.
DeLeon DD, Bakker B, Wilson DM, Hintz RL, Rosenfeld RG, 1988. Demonstration of insulin-like growth factor (IGF-I and-II) receptors and binding protein in human breast cancer cell lines. Biochem Biophys Res Comm 152:398–405.
Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N, 1990. Insulin-like growth factor receptor expression and function in human breast cancer 50:48–53.
Flier JS, Usher P, Moses AC, 1986. Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: Clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts. Proc Natl Acad Sci USA 83:664–668.
Rohlik QT, Adams D, Kull FC Jr, Jacobs S, 1987. An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. Biochem Biophys Res Comm 149:276–281.
Arteaga CL, Kitten L, Coronado EB, Jacobs S, Kull FC, Osborne CK, 1989. Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 84:1418–1423.
Murphy LJ, Friesen HG, 1988. Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growh factor I gene expression in the ovariectomized hypohysectomized rat. Endocrinology 122:325–332.
Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF, 1989. Studies of HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707–712.
Pollack MN, Perdue JF, Margolese RG, Baer K, Richard M, (1987). Presence of somatomedin receptors on human breast and colon carcinomas. Cancer lett 38:223–230.
Peyrat J-P, Bonneterre J, Beuscart J, Dijane J, Demaille A, 1988. Insulin-like growth factor I receptors in human breast cancer and their relation to estradiol and progesterone receptors. Cancer Res 48:6429–6433.
Peyrat JP, Bonneterre J, Laurent JC, Louchez MM, Amrani S, Leroy-Martin B, Vilain MO, Delobelle A, Demaille A, 1988. Presence and characterization of insulin-like growth factor 1 receptors in human benign breast disease. Eur J Cancer Clin Oncol 24:1425–1431.
Huff KK, Kaufman D, Gabby KH, Spencer EM, Lippman ME, Dickson RB, 1986. Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. Cancer Res 46:4613–4619.
Minuto F, DelMonte P, Barreca A, Nicolin A, Giordano G, 1987. Partial characterization of somatomedin C-like immunoreactivity secreted by breast cancer cellsin vitro. Mol Cell Endo 54:179–184.
Osborne CK, Ross CR, Coronado EB, Fuqua SA, Kitten LJ, 1988. Secreted growth factors from estrogen receptor-negative human breast cancer do not support growth of estrogen receptor-positive breast cancer in the nude mouse model. Breast Cancer Res Treat 11:211–219.
Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, Cullen KJ, Lippman ME, Rosen N, 1989. Analysis of IGF-I gene expression in malignancy, evidence for a paracrine role in human breast cancer. Mol Endocrlrol 3:509–517.
Peres R, Betsholtz C, Westermark B, Heldin C-H, 1987. Frequent expression of growth factors for mesenchymal cells in human mammary carcinoma cell lines. Cancer Res 47:3425–3429.
Cullen KJ, Lippman ME, 1989. Estrogen regulation of protein synthesis and cell growth in human breast cancer. In Vitamins and Hormones, Vol 45, (Aurbach GD, ed) New York: Academic Press.
Brünner N, Cullen KJ, Yee D, Spang-Thomsen M, Lippman ME, Rosen N, Gelman E, Kern FG, 1989. Differential regulation by estradiol (E2) of IGF-I and IGF-II mRNA expression during E2-induced growth inhibition of the T61 human breast cancer xenograft. Proc Endocr Soc A288.
Travers MT, Barrett-Lee PJ, Berger U, Luqmani YA, Gazet J-C, Powles TJ, Coombes RC, 1988. Growth factor expression in normal, benign, and malignant breast tissue. Br Med J 296:1621–1624.
Han VKM, D’Ercole AJ, Lund PK, 1987. Cellular localization of somatomedin messenger RNA in the human fetus. Science 236:193–197.
Copeland KC, 1988. Effects of acute high dose and chronic low dose estrogen on plasma somatomedin-C and growth in patients with Turner’s syndrome. J Clin Endocrinol Metab 66:1278–1282.
Colletti RB, Roberts JD, Devlin JT, Copeland KC, 1989. Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer. Cancer Res 49:1882–1884.
DeLeon DD, Wilson DM, Bakker B, Lamsom G, Hintz RL, Rosenfeld RG, 1989. Characterization of insulin-like growth factor (IGF) binging proteins from human breast cancer cells. Mol Endocrinol 3:567–574.
Yee D, Favoni RE, Lupu R, Cullen KJ, Lebovic GS, Huff KK, Lee PDK, Lee YL, Powell DR, Dickson RB, Rosen N, Lippman ME, 1989. The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells. Biochem Biophys Res Comm 158:38–44.
Elgin RG, Busby WH Jr, Clemmons DR, 1987. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA 84:3254–3258.
Favoni RE, Cubbage M, Powell DR, Lippman ME, Rosen N, Yee D, 1989. Multiple insulin-like growth factor binding proteins are produced by human breast cancer cells. Br Cancer Res Treat 14:A168.
Hossenlopp P, Seurin D, Seovia-Quinson B, Hardouin S, Binoxu, M, 1986. Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154:138–143.
Rosenfeld RG, Pham H, Conover CA, Hintz RL, Baxter RC, 1989. Structural and immu-nological comparison of insulin-like growth factor binding proteins of cerebrospinal and amniotic fluids. J Clin Endocrinol Metab 68:638–646.
Reichman E, Ball R, Groner B, Friis RR, 1989. New mammary epithelial and fibroblastic cell clones in coculture form structures competent to differentiate functionally. J Cell Biol 108:1127–1138.
Bronzert DA, Pantazis P, Antoniades HN, Kasid A, Davidson N, Dickson RB, Lippman ME, 1987. Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines. Proc Natl Acad Sci 84:5763–5767.
Peres R, Betsholtz C, Westermark B, Heldin C-H, 1987. Frequent expression of growth factors for mesenchymal cells in human mammary carcinoma cell lines. Cancer Res 47:3425–3429.
Clemmons DR, 1984. Multiple hormones stimulate the production of somatomedin by cultured human fibroblasts. J Clin Endo Metab 58:850–856.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Yee, D., Rosen, N., Favoni, R.E., Cullen, K.J. (1991). The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer. In: Lippman, M.E., Dickson, R.B. (eds) Regulatory Mechanisms in Breast Cancer. Cancer Treatment and Research, vol 53. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3940-7_5
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3940-7_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6758-1
Online ISBN: 978-1-4615-3940-7
eBook Packages: Springer Book Archive